The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 29, 2022
Filed:
Jan. 22, 2018
Applicant:
Foundation Medicine, Inc., Cambridge, MA (US);
Inventors:
Maureen T. Cronin, Boston, MA (US);
Garrett Michael Frampton, Somerville, MA (US);
Doron Lipson, Cambridge, MA (US);
Vincent A. Miller, West Orange, NJ (US);
Gary Palmer, Waltham, MA (US);
Jeffrey S. Ross, Lebanon Springs, NY (US);
Philip James Stephens, Lexington, MA (US);
Roman Yelensky, Newton, MA (US);
Assignee:
FOUNDATION MEDICINE, INC., Cambridge, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6886 (2018.01); A61K 31/565 (2006.01); A61K 31/4196 (2006.01); A61K 31/675 (2006.01); A61K 31/439 (2006.01); A61K 31/567 (2006.01); A61K 31/416 (2006.01); A61K 31/423 (2006.01); A61K 31/428 (2006.01); A61K 31/437 (2006.01); A61K 31/4439 (2006.01); A61K 31/472 (2006.01); A61K 31/536 (2006.01); A61K 31/5415 (2006.01); A61K 45/06 (2006.01); C07K 14/72 (2006.01); C07K 16/28 (2006.01); A61K 31/436 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); A61K 31/416 (2013.01); A61K 31/4196 (2013.01); A61K 31/423 (2013.01); A61K 31/428 (2013.01); A61K 31/436 (2013.01); A61K 31/437 (2013.01); A61K 31/439 (2013.01); A61K 31/4439 (2013.01); A61K 31/472 (2013.01); A61K 31/536 (2013.01); A61K 31/5415 (2013.01); A61K 31/565 (2013.01); A61K 31/567 (2013.01); A61K 31/675 (2013.01); A61K 45/06 (2013.01); C07K 14/72 (2013.01); C07K 16/2869 (2013.01); C07K 2317/34 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/156 (2013.01);
Abstract
Novel mutant ESR1 molecules and uses are disclosed.